ANGELA D WILKE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner SAN ANGELO, TX NPI 1669651964

General Payments — all program years on this page

$962.23

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 56
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $348.18 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $348.1819

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $107.685
Novo Nordisk AS $74.505
Acerta Pharma LLC $45.763
GlaxoSmithKline, LLC. $33.592
ABBVIE INC. $28.021
Sumitomo Pharma America, Inc. $25.401
PFIZER INC. $17.421
Exact Sciences Corporation $15.811

By program year

Program yearAmountRecords
2021 $333.2721
2022 $105.956
2023 $174.8310
2024 $348.1819

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100238058 Novo Nordisk Inc $14.42 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100238296 Novo Nordisk Inc $13.53 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100306695 Novo Nordisk Inc $14.10 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100339260 Novo Nordisk Inc $16.59 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100558833 Novo Nordisk Inc $15.86 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104510774 AstraZeneca Pharmaceuticals LP $16.34 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104683687 AstraZeneca Pharmaceuticals LP $15.41 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105275656 AstraZeneca Pharmaceuticals LP $14.01 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108411793 ABBVIE INC. $28.02 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114442853 Exact Sciences Corporation $15.81 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116014723 GlaxoSmithKline, LLC. $16.15 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116440549 GlaxoSmithKline, LLC. $17.44 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130989085 PFIZER INC. $17.42 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135447853 Lilly USA, LLC $23.66 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135501462 Lilly USA, LLC $25.19 12/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135501464 Lilly USA, LLC $18.02 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135511687 Lilly USA, LLC $20.68 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135524951 Lilly USA, LLC $20.13 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149004111 Sumitomo Pharma America, Inc. $25.40 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.